Treatment of child anxiety disorder in the context of maternal anxiety: A randomised controlled trial

Completed

You are on the General Public view
  • Source

    -
    Public Title Treatment of child anxiety disorder in the context of maternal anxiety: A randomised controlled trial
    Acronym The MaCh Trial
    Source of Record URL http://isrctn.org/ISRCTN19762288
  • Trial

    -
    Health Condition(s) or Problem Mental and behavioural disorders
    Lay Summary Not provided at time of registration (from ISRCTN)
    Who can enter the trial Current inclusion criteria as of 21/03/2012 Child: 1. Aged 7 to 12 years 2. Primary diagnosis of DSM-IV generalised anxiety disorder, social phobia, separation anxiety disorder , panic disorder/agoraphobia or specific phobia, co-morbid with one of the previous disorders 3. Absence of significant physical or intellectual impairment (including autistic spectrum disorders) Mother: 1. Primary carer 2. Current maternal DSM-IV anxiety disorder 3. Absence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence) For both the mother and child: Absence of psychotropic medication (or, if psychotropic medication is prescribed, it should have been at a stable dose for at least one month with agreement to maintain that dose throughout the study) Previous inclusion criteria Child: 1. Aged 7 to 12 years 2. Primary diagnosis of Diagnostic and Statistical Manual of Mental Disorders - fourth edition (DSM-IV) generalised anxiety disorder, social phobia, or separation anxiety disorder 3. Absence of significant physical or intellectual impairment (including autistic spectrum disorders) Mother: 1. Primary carer 2. Current maternal DSM-IV anxiety disorder 3. Absence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence) For both the mother and child: Absence of psychotropic medication (or, if psychotropic medication is prescribed, it should have been at a stable dose for at least one month with agreement to maintain that dose throughout the study)
    Who cannot enter the trial Child: 1. Aged less than 7 or over 12 years 2. No primary diagnosis of DSM-IV generalised anxiety disorder, social phobia, or separation anxiety disorder 3. Presence of significant physical or intellectual impairment (including autistic spectrum disorders) Mother: 1. Is not primary carer 2. Absence of current maternal DSM-IV anxiety disorder 3. Presence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence) For both the mother and child: Presence of psychotropic medication at a stable dose for less than one month
    What will happen Current interventions as of 24/04/2012 Arm 1: CCBT + MCBT + MCI control Arm 2: CCBT + MCBT control + MCI Arm 3: CCBT + MCBT control + MCI control MCBT: CBT for maternal anxiety disorder This will consist of an eight-session (one hour each) intervention for mothers delivered by a clinical psychologist (or equivalent) over eight weeks. Sessions will take place in the participants' local Child and Adolescent Mental Health Service (CAMHS), within their home, or at the University of Reading. The programme will follow a manualised transdiagnostic treatment for adult anxiety disorders. MCBT control: Supportive Counselling This will consist of either two or eight sessions (one hour each) of supportive counselling, delivered by a clinical psychologist (or equivalent) over eight weeks. Sessions will take place in the participants' local CAMHS, within their home, or at the University of Reading. The supportive counselling programme will follow a manualised treatment. CCBT: CBT for child anxiety disorder All participating children will receive an eight-session (one hour each) intervention based on the Cool Kids programme, delivered by a clinical psychologist (or equivalent) over eight weeks. Sessions will take place in the participants' local CAMHS, within their home, or at the University of Reading. MCI : Treatment of mother-child interaction This intervention consists of 10 sessions; eight with the mother alone and two with the mother and child together. This is a novel intervention which specifically targets anxiogenic features of the mother-child relationship. Specifically it aims to enhance maternal cognitions associated with child competence, reduce maternal overcontrol/overprotection, and enhance maternal warmth and encouragement. This is achieved through a combination of specific materials from existing family interventions for childhood anxiety and video-feedback techniques developed and piloted by the trial investigators. This intervention is provided by a clinical psychologist (or equivalent) in parallel with the CCBT sessions. Sessions will generally take place in the participants' local CAMHS, within their home, or at the University of Reading. The two mother and child sessions will be conducted within the laboratory at the University of Reading, as these involve the mother and child completing structured tasks which are video-recorded for feedback purposes. MCI control: Family Lifestyle Management This will consist of four sessions, two with the mother alone and two with the mother and child together. These sessions will focus on promoting a healthy lifestyle with a focus on family diet and exercise, based on existing packages applied within school settings. This intervention is provided by a clinical psychologist (or equivalent) in parallel with the CCBT sessions. Sessions will generally take place in the participants' local CAMHS, within their home, or at the University of Reading. For all treatment conditions, therapists will routinely rate the extent to which participants adhere to the intervention (e.g. completion of in-session and homework exercises, session attendance). Previous interventions Arm 1: CCBT + MCBT (CBT for maternal anxiety disorder) + MCI control (Treatment of mother-child interaction) Arm 2: CCBT + MCBT control + MCI Arm 3: CCBT + MCBT control + MCI control MCBT control: This will consist of an eight-session (one hour each) intervention for mothers delivered by a clinical psychologist (or equivalent) over eight weeks. Sessions will take place in the participants' local Child and Adolescent Mental Health Service (CAMHS), within their home, or at the University of Reading. The programme will follow a manualised transdiagnostic treatment for adult anxiety disorders. MCBT control: Supportive Counselling. This will consist of either two or eight sessions (one hour each) of supportive counselling, delivered by a clinical psychologist (or equivalent
    Primary aim The primary outcome is child anxiety (assessed both categorically [i.e. diagnosis] and continuously [i.e. symptoms]). Diagnostic status will be assessed by the Anxiety Disorders Interview Schedule (ADIS) for DSM-IV: C/P administered to both the mother and child. Assessors will be blind to treatment condition. Assessors' beliefs about treatment condition will be formally assessed. Child anxiety symptoms will be assessed using questionnaires (Spence Children's Anxiety Scale [SCAS]) administered to the child, the mother and the child's teacher. These measures will be administered post-treatment, and at 6 and 12 month follow-up assessments.
    Secondary Aim 1. Maternal anxiety, assessed categorically using the ADIS (DSM-IV) post-treatment, and at 6- and 12-month follow-up assessments 2. Maternal anxiety, assessed continuously using the following questionnaires post-treatment, and at 6- and 12-month follow-up assessments: 2.1. Depression Anxiety and Stress Scales (DASS) 2.2. Penn State Worry Questionnaire (PSWQ) 2.3. Social Interaction Anxiety Scale (SIAS) 2.4. Social Phobia Scale (SPS) 3. Maternal interactive behaviours will be assessed by filming the mother assisting the child perform an anxiety provoking task and applying standardised ratings of anxiogenic behaviours (i.e. modelling, lack of encouragement, overcontrol/overprotection). Interactive behaviours will be coded by independent, trained, reliable raters. Coders will be blind to the purpose and conditions of the trial. Maternal cognitions will be assessed by a standardised interview. These measures will be conducted at the post-treatment assessment.
    Participant Information Sheet Not available in web format, please use the contact details below to request a patient information sheet
    Website Sorry, not currently available
    Recruitment Status Completed
    Nation England
    Location Reading
  • Contact

    -
    Contact for Public Queries Prof Peter Cooper School of Psychology University of Reading Whiteknights Berkshire Reading RG6 6AL United Kingdom p.j.cooper@reading.ac.uk
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.